9-[(2-amino-4,5-dihydro-1H-imidazol-5-yl)-hydroxymethyl]-12-[(3-amino-4-hydroxyphenyl)methyl]-6-[[2-amino-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-4,5-dihydroimidazol-4-yl]-hydroxymethyl]-3-(hydroxymethyl)-15-[(3-methylphenyl)methyl]-1,4,7,10,13,16-hexazacyclooctadecane-2,5,8,11,14,17-hexone

C42H59N13O15 — CID 87319609

IUPAC9-[(2-amino-4,5-dihydro-1H-imidazol-5-yl)-hydroxymethyl]-12-[(3-amino-4-hydroxyphenyl)methyl]-6-[[2-amino-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-4,5-dihydroimidazol-4-yl]-hydroxymethyl]-3-(hydroxymethyl)-15-[(3-methylphenyl)methyl]-1,4,7,10,13,16-hexazacyclooctadecane-2,5,8,11,14,17-hexone
SMILESCc1cccc(CC2NC(=O)CNC(=O)C(CO)NC(=O)C(C(O)C3CN=C(N)N3C3OC(CO)C(O)C(O)C3O)NC(=O)C(C(O)C3CN=C(N)N3)NC(=O)C(Cc3ccc(O)c(N)c3)NC2=O)c1
InChIInChI=1S/C42H59N13O15/c1-16-3-2-4-17(7-16)9-20-36(66)50-21(10-18-5-6-25(58)19(43)8-18)37(67)53-28(30(60)22-11-47-41(44)52-22)39(69)54-29(38(68)51-23(14-56)35(65)46-13-27(59)49-20)31(61)24-12-48-42(45)55(24)40-34(64)33(63)32(62)26(15-57)70-40/h2-8,20-24,26,28-34,40,56-58,60-64H,9-15,43H2,1H3,(H2,45,48)(H,46,65)(H,49,59)(H,50,66)(H,51,68)(H,53,67)(H,54,69)(H3,44,47,52)
InChIKeyRTTGYYCAHGNLTE-UHFFFAOYSA-N
MW986.01 g/mol
LogP-9.58
Rot. Bonds11

About 9-[(2-amino-4,5-dihydro-1H-imidazol-5-yl)-hydroxymethyl]-12-[(3-amino-4-hydroxyphenyl)methyl]-6-[[2-amino-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-4,5-dihydroimidazol-4-yl]-hydroxymethyl]-3-(hydroxymethyl)-15-[(3-methylphenyl)methyl]-1,4,7,10,13,16-hexazacyclooctadecane-2,5,8,11,14,17-hexone

9-[(2-amino-4,5-dihydro-1H-imidazol-5-yl)-hydroxymethyl]-12-[(3-amino-4-hydroxyphenyl)methyl]-6-[[2-amino-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-4,5-dihydroimidazol-4-yl]-hydroxymethyl]-3-(hydroxymethyl)-15-[(3-methylphenyl)methyl]-1,4,7,10,13,16-hexazacyclooctadecane-2,5,8,11,14,17-hexone (PubChem CID 87319609) has the molecular formula C42H59N13O15 and a molecular weight of 986.01 g/mol. Its IUPAC name is 9-[(2-amino-4,5-dihydro-1H-imidazol-5-yl)-hydroxymethyl]-12-[(3-amino-4-hydroxyphenyl)methyl]-6-[[2-amino-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-4,5-dihydroimidazol-4-yl]-hydroxymethyl]-3-(hydroxymethyl)-15-[(3-methylphenyl)methyl]-1,4,7,10,13,16-hexazacyclooctadecane-2,5,8,11,14,17-hexone.

Molecular Properties

Compound Name9-[(2-amino-4,5-dihydro-1H-imidazol-5-yl)-hydroxymethyl]-12-[(3-amino-4-hydroxyphenyl)methyl]-6-[[2-amino-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-4,5-dihydroimidazol-4-yl]-hydroxymethyl]-3-(hydroxymethyl)-15-[(3-methylphenyl)methyl]-1,4,7,10,13,16-hexazacyclooctadecane-2,5,8,11,14,17-hexone
PubChem CID87319609
Molecular FormulaC42H59N13O15
Molecular Weight986.01 g/mol
Exact Mass985.43
IUPAC Name9-[(2-amino-4,5-dihydro-1H-imidazol-5-yl)-hydroxymethyl]-12-[(3-amino-4-hydroxyphenyl)methyl]-6-[[2-amino-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-4,5-dihydroimidazol-4-yl]-hydroxymethyl]-3-(hydroxymethyl)-15-[(3-methylphenyl)methyl]-1,4,7,10,13,16-hexazacyclooctadecane-2,5,8,11,14,17-hexone
SMILESCc1cccc(CC2NC(=O)CNC(=O)C(CO)NC(=O)C(C(O)C3CN=C(N)N3C3OC(CO)C(O)C(O)C3O)NC(=O)C(C(O)C3CN=C(N)N3)NC(=O)C(Cc3ccc(O)c(N)c3)NC2=O)c1
InChIInChI=1S/C42H59N13O15/c1-16-3-2-4-17(7-16)9-20-36(66)50-21(10-18-5-6-25(58)19(43)8-18)37(67)53-28(30(60)22-11-47-41(44)52-22)39(69)54-29(38(68)51-23(14-56)35(65)46-13-27(59)49-20)31(61)24-12-48-42(45)55(24)40-34(64)33(63)32(62)26(15-57)70-40/h2-8,20-24,26,28-34,40,56-58,60-64H,9-15,43H2,1H3,(H2,45,48)(H,46,65)(H,49,59)(H,50,66)(H,51,68)(H,53,67)(H,54,69)(H3,44,47,52)
InChIKeyRTTGYYCAHGNLTE-UHFFFAOYSA-N
XLogP-9.58
TPSA463.72 Ų
H-Bond Donors18
H-Bond Acceptors22
Rotatable Bonds11
Heavy Atoms70
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500986.01
LogP ≤ 5-9.58
H-Bond Donors ≤ 518
H-Bond Acceptors ≤ 1022

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aniline', 'substructure': 'N/A'}, {'alert_name': 'catechol', 'substructure': 'N/A'}

Analyze 9-[(2-amino-4,5-dihydro-1H-imidazol-5-yl)-hydroxymethyl]-12-[(3-amino-4-hydroxyphenyl)methyl]-6-[[2-amino-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-4,5-dihydroimidazol-4-yl]-hydroxymethyl]-3-(hydroxymethyl)-15-[(3-methylphenyl)methyl]-1,4,7,10,13,16-hexazacyclooctadecane-2,5,8,11,14,17-hexone with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 9-[(2-amino-4,5-dihydro-1H-imidazol-5-yl)-hydroxymethyl]-12-[(3-amino-4-hydroxyphenyl)methyl]-6-[[2-amino-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-4,5-dihydroimidazol-4-yl]-hydroxymethyl]-3-(hydroxymethyl)-15-[(3-methylphenyl)methyl]-1,4,7,10,13,16-hexazacyclooctadecane-2,5,8,11,14,17-hexone?
The IUPAC name of 9-[(2-amino-4,5-dihydro-1H-imidazol-5-yl)-hydroxymethyl]-12-[(3-amino-4-hydroxyphenyl)methyl]-6-[[2-amino-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-4,5-dihydroimidazol-4-yl]-hydroxymethyl]-3-(hydroxymethyl)-15-[(3-methylphenyl)methyl]-1,4,7,10,13,16-hexazacyclooctadecane-2,5,8,11,14,17-hexone (CID 87319609) is 9-[(2-amino-4,5-dihydro-1H-imidazol-5-yl)-hydroxymethyl]-12-[(3-amino-4-hydroxyphenyl)methyl]-6-[[2-amino-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-4,5-dihydroimidazol-4-yl]-hydroxymethyl]-3-(hydroxymethyl)-15-[(3-methylphenyl)methyl]-1,4,7,10,13,16-hexazacyclooctadecane-2,5,8,11,14,17-hexone.
What is the SMILES notation for 9-[(2-amino-4,5-dihydro-1H-imidazol-5-yl)-hydroxymethyl]-12-[(3-amino-4-hydroxyphenyl)methyl]-6-[[2-amino-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-4,5-dihydroimidazol-4-yl]-hydroxymethyl]-3-(hydroxymethyl)-15-[(3-methylphenyl)methyl]-1,4,7,10,13,16-hexazacyclooctadecane-2,5,8,11,14,17-hexone?
The canonical SMILES for 9-[(2-amino-4,5-dihydro-1H-imidazol-5-yl)-hydroxymethyl]-12-[(3-amino-4-hydroxyphenyl)methyl]-6-[[2-amino-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-4,5-dihydroimidazol-4-yl]-hydroxymethyl]-3-(hydroxymethyl)-15-[(3-methylphenyl)methyl]-1,4,7,10,13,16-hexazacyclooctadecane-2,5,8,11,14,17-hexone is Cc1cccc(CC2NC(=O)CNC(=O)C(CO)NC(=O)C(C(O)C3CN=C(N)N3C3OC(CO)C(O)C(O)C3O)NC(=O)C(C(O)C3CN=C(N)N3)NC(=O)C(Cc3ccc(O)c(N)c3)NC2=O)c1.
What is the InChIKey of 9-[(2-amino-4,5-dihydro-1H-imidazol-5-yl)-hydroxymethyl]-12-[(3-amino-4-hydroxyphenyl)methyl]-6-[[2-amino-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-4,5-dihydroimidazol-4-yl]-hydroxymethyl]-3-(hydroxymethyl)-15-[(3-methylphenyl)methyl]-1,4,7,10,13,16-hexazacyclooctadecane-2,5,8,11,14,17-hexone?
The InChIKey is RTTGYYCAHGNLTE-UHFFFAOYSA-N. The full InChI is InChI=1S/C42H59N13O15/c1-16-3-2-4-17(7-16)9-20-36(66)50-21(10-18-5-6-25(58)19(43)8-18)37(67)53-28(30(60)22-11-47-41(44)52-22)39(69)54-29(38(68)51-23(14-56)35(65)46-13-27(59)49-20)31(61)24-12-48-42(45)55(24)40-34(64)33(63)32(62)26(15-57)70-40/h2-8,20-24,26,28-34,40,56-58,60-64H,9-15,43H2,1H3,(H2,45,48)(H,46,65)(H,49,59)(H,50,66)(H,51,68)(H,53,67)(H,54,69)(H3,44,47,52).
What are the key properties of 9-[(2-amino-4,5-dihydro-1H-imidazol-5-yl)-hydroxymethyl]-12-[(3-amino-4-hydroxyphenyl)methyl]-6-[[2-amino-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-4,5-dihydroimidazol-4-yl]-hydroxymethyl]-3-(hydroxymethyl)-15-[(3-methylphenyl)methyl]-1,4,7,10,13,16-hexazacyclooctadecane-2,5,8,11,14,17-hexone?
9-[(2-amino-4,5-dihydro-1H-imidazol-5-yl)-hydroxymethyl]-12-[(3-amino-4-hydroxyphenyl)methyl]-6-[[2-amino-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-4,5-dihydroimidazol-4-yl]-hydroxymethyl]-3-(hydroxymethyl)-15-[(3-methylphenyl)methyl]-1,4,7,10,13,16-hexazacyclooctadecane-2,5,8,11,14,17-hexone has a molecular weight of 986.01 g/mol, XLogP of -9.58, 11 rotatable bonds, 18 hydrogen bond donors, and 22 hydrogen bond acceptors.
Where does this data come from?
All data for 9-[(2-amino-4,5-dihydro-1H-imidazol-5-yl)-hydroxymethyl]-12-[(3-amino-4-hydroxyphenyl)methyl]-6-[[2-amino-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-4,5-dihydroimidazol-4-yl]-hydroxymethyl]-3-(hydroxymethyl)-15-[(3-methylphenyl)methyl]-1,4,7,10,13,16-hexazacyclooctadecane-2,5,8,11,14,17-hexone is sourced from PubChem (CID 87319609), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).